WebBottom Line. Phentermine is a great weight loss drug and it already helped thousands of people to successfully lose weight. But as I mentioned above, this drug is not for people with underlying diseases such as those who have heart diseases or has a family history of stroke, high blood pressure and many others. WebWe conclude that there is unlikely to be a substantial N Engl J Med 1997; 337:1773. increased risk of first-time stroke attributable to the use 8 Kokkinos J, Levine SR. Possible association of ischemic of fenfluramine, dexfenfluramine or phentermine. stroke with phentermine. Stroke 1993; 24: 310–313.
Can phentermine cause heart failure? Risks, long-term effects and …
Web15. máj 2024 · Here are seven ways to start reining in your risks today to avoid stroke, before a stroke has the chance to strike. 1. Lower blood pressure. High blood pressure is a huge factor, doubling or even … WebThere has also been reports of 2 patients without ischemic risk factors taking phentermine presenting with ischemic stroke. This may have been secondary to cerebrovascular vasospasm leading to ischemia and subsequent neurological deficits as has been described in patients taking amphetamines. randall exterior construction
Can phentermine cause heart failure? Risks, long-term effects and …
Web1. dec 2024 · Cardiovascular disease is a contraindication to phentermine because of concerns about increased blood pressure and pulse rate, although these concerns seem to be more theoretic than observed. 16 Other contraindications include hyperthyroidism, glaucoma, agitation, a history of drug abuse, pregnancy, breastfeeding, and current or … Web10. feb 2024 · Phentermine is a sympathomimetic amine with pharmacologic properties similar to the amphetamines. ... (BMI) ≥30 kg/m 2 or ≥27 kg/m 2 in the presence of other risk factors (eg ... heart failure, coronary artery disease, stroke, uncontrolled hypertension); hyperthyroidism; glaucoma; agitated states; history of drug abuse; use during or within ... WebPhentermine Hydrochloride, USP 15 mg and 30 mg is indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index greater than or equal to 30 kg/m 2, or greater than or equal to 27 kg/m 2 … randall fairbanks attorney